Clinical Trial Update: Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating docetaxel with or without thalidomide in metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Prostate
• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Thalidomide (thalidomide)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Stage IV Prostate Cancer, Adenocarcinoma of the Prostate | Phase 2 | Status: COMPLETED